Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Bock

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|December 24, 1993
Development of 1,4-benzodiazepine cholecystokinin type B antagonistsM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
European Journal of Pharmacology|December 8, 2000
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonistR S Chang, T B Chen, S S O'Malley, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|December 24, 1993
Development of 1,4-benzodiazepine cholecystokinin type B antagonistsM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
European Journal of Pharmacology|December 8, 2000
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonistR S Chang, T B Chen, S S O'Malley, et al.
Pageof 4